A high-throughput glycosyltransferase inhibition assay to identify molecules targeting fucosylation in cancer cell-surface modification

<none>

Programme Social programme Plenary speakers Keynote speakers 1st EuroCarb Young Researcher (ECYR) Workshop CarboMet Workshop Mini symposium: Glycobiology at the LUMC and beyond Favourites/Agenda

Social programme

Plenary speakers

Keynote speakers

1st EuroCarb Young Researcher (ECYR) Workshop

CarboMet Workshop

Mini symposium: Glycobiology at the LUMC and beyond

Favourites/Agenda

Photos

Venue & Travel Venue Accommodation City of Leiden Travel directions

Venue

Accommodation

City of Leiden

Travel directions

Committees

Home

A high-throughput glycosyltransferase inhibition assay to identify molecules targeting fucosylation in cancer cell-surface modification

David Kwan 1 , Xiaohua Zhang 1 , Fei Chen 1 , Alessandro Petrella 1 , Franklin Chacón-Huete 1 , Jason Covone 1 , Teng-Wei Tsai 2 , Ching-Ching Yu 2 , Pat Forgione 1

1 Concordia University, Montreal, Canada, 2 National Chung Cheng University, Chiayi, Taiwan

In cancers, increased fucosylation (attachment of fucose sugar residues) on cell-surface glycans—resulting from the abnormal upregulation in the expression of specific fucosyltransferase enzymes (FUTs)—is one of the most important types of glycan modifications associated with malignancy. Fucosylated glycans on cell surfaces are involved in a multitude of cellular interactions and signal regulation in normal biological processes. For example, sialyl Lewis-X is a fucosylated cell-surface glycan that is abnormally abundant in some cancers where it has been implicated in facilitating metastasis, allowing circulating tumor cells to bind to the epithelial tissue within blood vessels and invade into secondary sites by taking advantage of glycan-mediated interactions.

To identify inhibitors of FUT enzymes as potential cancer therapeutics, we have developed a novel high-throughput assay that makes use of a fluorogenically labeled oligosaccharide as a probe of fucosylation. This probe, which consists of a 4-methylumbelliferyl glycoside, is recognized and hydrolyzed by specific glycoside hydrolase enzymes to release fluorescent 4-methylumbelliferone, yet when the probe is fucosylated prior to treatment with the glycoside hydrolases, hydrolysis does not occur and no fluorescent signal is produced. We have demonstrated that this assay can be used to measure the inhibition of FUT enzymes by small molecules, since blocking fucosylation will allow glycosidase-catalyzed hydrolysis of the labeled oligosaccharide to produce a fluorescent signal.

Employing this assay, we have screened a focused library of small molecules for inhibitors of a human FUT enzyme involved in the synthesis of sialyl Lewis-X, and demonstrate that our approach can be used to identify potent FUT inhibitors from compound libraries in microtitre plate-format.

Fig 1: A fluorescence-based inhibition assay of fucosyltransferase activity.

Contact eurocarb@eurocarb2019.com for general questions about EUROCARB2019, or codee@eurocarb2019.com for scientific questions.

Leiden University / Leiden Institute of Chemistry lic.leidenuniv.nl

European Carbohydrate Organisation

Congress by Design www.congressbydesign.com